MLRS 242 Immunology Pat Reed Antibodies Serum proteins General antibody structure Enzyme digestion fragments.
Download ReportTranscript MLRS 242 Immunology Pat Reed Antibodies Serum proteins General antibody structure Enzyme digestion fragments.
MLRS 242 Immunology Pat Reed Antibodies
Serum proteins
General antibody structure
Enzyme digestion fragments
Protein structure of immunoglobulins • Early amino acid sequence experiments were unsuccessful —too much variation • Multiple myeloma serum is 95% same antibody • Bence-jones protein found in urine of myeloma patients is excess light chain • 110 amino acids highly variable, rest are quite constant • 5 different isotypes identified: based on type of heavy chain: G,D,E,M,A • Human light chains: 60% kappa (K) chains, 40% lambda (L) chains
Ribbon model of antibody
Detailed structure of antibody
Ribbon model of variable region • Variable region contains highly variable connecting regions called complementarity determining regions or CDRs • These regions are also shown to be the antigen binding sites
Model of antibody
Amino acid diversity of variable domains – complementarity determining regions (CDRs)
Antigen – antibody interaction
Space filling model
Hiv protease and Fab fragment Conformational change in Fab domain
General structures of different antibody classes
Subclasses of IgG
Secretory IgA
Receptor bound IgE
• Isotype – different species • Allotype – same species, different alleles • Idiotype – same species, different V H and V L domains
Isotypic determinants – different species variation within the constant region
Allotypic determinants – different constant regions within the same species – different alleles
Idiotypic determinants – variations in the variable region within the same antibody type
B Cell Receptor - BCR
Fc receptors – bind Fc portion of antibody molecules
Immunoglobulin superfamily of cell receptors – evolved from common ancestor gene
More members of the Ig superfamily
Monoclonal antibodies
Many uses for monoclonal antibodies
Antibodies can deliver drugs to specific targets